Most companies are likely going to feel the impact of President Trump's tariffs. In the video above, BofA Securities senior ...

Owned by Vietnam’s wealthiest man, VinFast is more immune to not making a profit. On Thursday, the company reported it lost ...

April 24 - A U.S. judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes and weight-loss drugs Ozempic and Wegovy while a legal challenge ...

Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...

U.S. District Judge Mark Pittman in Texas denied compounders' bid for a preliminary injunction, according to the court docket ...

Along with the rest of the market, Novo Nordisk (NYSE:NVO) has been sinking this year – with losses approaching 30% ...

But recent weak U.S. prescription data is leading some investors and analysts to question whether that stellar run, which ...

Carter Worth, Worth Charting, talks technicals on Morgan Stanley and Novo Nordisk. The Dallas Wings introduced their newest ...

"European price controls and austerity measures reduce the attractiveness of its markets," Novartis CEO Vas Narasimhan and ...

Chinese carmaker Guangzhou Automobile Group (GAC) said at the Shanghai auto show on Wednesday it would take responsibility ...

Even though the stock is down notably from the peak price it hit last year, it's still doing far better than in the pre-approval days. Competitors are biting at its heels in the weight loss segment, ...

In a week marked by mixed performances across major global indices and heightened trade tensions, investors are navigating an environment of policy uncertainty and economic caution. As central banks ...